G. Sengoelge

发表

Effect of Conversion From Ciclosporin to Tacrolimus on Endothelial Progenitor Cells in Stable Long-Term Kidney Transplant Recipients

W. Winkelmayer, G. Sunder-Plassmann, Max Plischke, 2013, Transplantation.

Lisinopril pharmacokinetics and erythropoietin requirement in haemodialysis patients

W. Hörl, M. Brunner, W. Winnicki, 2012, European journal of clinical investigation.

The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran

J. Levy, C. Ay, A. Spiel, 2017, Journal of thrombosis and haemostasis : JTH.

Individualization of Mycophenolic Acid Therapy through Pharmacogenetic, Pharmacokinetic and Pharmacodynamic Testing

W. Winnicki, H. Herkner, S. Zelzer, 2022, Biomedicines.

An inosine 5′-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid

H Herkner, G. Weigel, W. Winnicki, 2010, The Pharmacogenomics Journal.

Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.

W. Winnicki, T. Reiter, G. Sunder-Plassmann, 2017, Kidney international.

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

M. Pirmohamed, A. Cambon-Thomsen, Yitian Zhou, 2023, The Lancet.

A SAGE based approach to human glomerular endothelium: defining the transcriptome, finding a novel molecule and highlighting endothelial diversity

A. von Haeseler, Michael Schuster, P. Jennings, 2014, BMC Genomics.

Individualization of Mycophenolic Acid Therapy through Pharmacogenetic, Pharmacokinetic and Pharmacodynamic Testing

W. Winnicki, H. Herkner, S. Zelzer, 2022, Biomedicines.